In a filing, Astera Labs Inc. revealed its Director HURLSTON MICHAEL E. acquired Company’s shares for reported $0.78 million on Mar 22 ’24. In the deal valued at $36.00 per share,21,747 shares were bought. As a result of this transaction, HURLSTON MICHAEL E. now holds 121,747 shares worth roughly $9.37 million.
Then, LAZAR JACK R bought 10,000 shares, generating $360,000 in total proceeds. Upon buying the shares at $36.00, the Director now owns 165,000 shares.
Before that, ALBA MANUEL bought 5,000 shares. Astera Labs Inc. shares valued at $180,000 were divested by the Director at a price of $36.00 per share. As a result of the transaction, ALBA MANUEL now holds 5,000 shares, worth roughly $0.38 million.
Evercore ISI initiated its Astera Labs Inc. [ALAB] rating to an Outperform in a research note published on April 16, 2024; the price target was $100. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating. ROTH MKM began covering ALAB with “Buy” recommendation on April 15, 2024. Needham started covering the stock on April 15, 2024. It rated ALAB as “a Buy”.
Price Performance Review of ALAB
On Friday, Astera Labs Inc. [NASDAQ:ALAB] saw its stock fall -2.66% to $76.96. Over the last five days, the stock has lost -9.46%. Astera Labs Inc. shares have risen nearly 24.07% since the year began.
Levels Of Support And Resistance For ALAB Stock
The 24-hour chart illustrates a support level at 75.23, which if violated will result in even more drops to 73.50. On the upside, there is a resistance level at 79.97. A further resistance level may holdings at 82.98. The Relative Strength Index (RSI) on the 14-day chart is 55.05, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.98, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 40.98%. Stochastics %K at 58.99% indicates the stock is a holding.
The most recent change occurred on April 15, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $81 price target.
